Xylem Inc (NYSE:XYL) – Equities researchers at Boenning Scattergood boosted their Q2 2018 earnings estimates for shares of Xylem in a note issued to investors on Friday. Boenning Scattergood analyst R. Connors now expects that the industrial products company will post earnings per share of $0.69 for the quarter, up from their previous forecast of $0.68. Boenning Scattergood has a “Buy” rating on the stock. Boenning Scattergood also issued estimates for Xylem’s Q4 2018 earnings at $0.91 EPS and FY2018 earnings at $2.82 EPS.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Tuesday, October 31st. The industrial products company reported $0.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.64 by $0.01. The business had revenue of $1.20 billion during the quarter, compared to analyst estimates of $1.18 billion. Xylem had a return on equity of 17.74% and a net margin of 6.85%. The company’s revenue for the quarter was up 33.2% on a year-over-year basis. During the same period last year, the company earned $0.54 EPS.

Several other equities research analysts have also issued reports on XYL. Stifel Nicolaus reaffirmed a “hold” rating and issued a $63.00 price objective on shares of Xylem in a research note on Tuesday, September 5th. Cowen reaffirmed a “buy” rating and issued a $70.00 price objective on shares of Xylem in a research note on Thursday, September 21st. Robert W. Baird reaffirmed a “hold” rating and issued a $67.00 price objective on shares of Xylem in a research note on Wednesday, October 4th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $71.00 price objective (up from $64.00) on shares of Xylem in a research note on Wednesday, October 4th. Finally, Zacks Investment Research raised Xylem from a “hold” rating to a “buy” rating and set a $71.00 price objective for the company in a research note on Thursday, October 5th. Seven equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $65.17.

Shares of Xylem (NYSE:XYL) opened at $67.57 on Monday. The stock has a market capitalization of $12,135.57, a P/E ratio of 29.51, a PEG ratio of 1.88 and a beta of 1.17. Xylem has a one year low of $46.67 and a one year high of $69.88. The company has a quick ratio of 1.26, a current ratio of 1.76 and a debt-to-equity ratio of 0.88.

Several hedge funds have recently modified their holdings of the stock. Parametric Portfolio Associates LLC lifted its stake in shares of Xylem by 8.2% during the 3rd quarter. Parametric Portfolio Associates LLC now owns 378,343 shares of the industrial products company’s stock worth $23,696,000 after acquiring an additional 28,679 shares during the last quarter. Public Employees Retirement System of Ohio increased its holdings in Xylem by 10.7% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 435,639 shares of the industrial products company’s stock worth $27,284,000 after purchasing an additional 42,266 shares during the period. GSA Capital Partners LLP purchased a new position in Xylem during the 3rd quarter worth $420,000. IFM Investors Pty Ltd purchased a new position in Xylem during the 3rd quarter worth $550,000. Finally, California Public Employees Retirement System increased its holdings in Xylem by 5.4% during the 3rd quarter. California Public Employees Retirement System now owns 518,932 shares of the industrial products company’s stock worth $32,501,000 after purchasing an additional 26,432 shares during the period. 85.57% of the stock is owned by hedge funds and other institutional investors.

In related news, insider Colin R. Sabol sold 38,070 shares of the firm’s stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $65.81, for a total transaction of $2,505,386.70. Following the completion of the sale, the insider now directly owns 61,979 shares of the company’s stock, valued at approximately $4,078,837.99. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Steven R. Loranger sold 37,700 shares of the firm’s stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $66.25, for a total value of $2,497,625.00. Following the sale, the director now directly owns 58,831 shares of the company’s stock, valued at $3,897,553.75. The disclosure for this sale can be found here. Insiders have sold a total of 83,666 shares of company stock valued at $5,528,289 over the last three months. 0.75% of the stock is owned by corporate insiders.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, December 6th. Investors of record on Thursday, November 2nd were paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.07%. The ex-dividend date was Wednesday, November 1st. Xylem’s dividend payout ratio is currently 41.86%.

WARNING: This story was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another domain, it was stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this story can be accessed at https://www.thecerbatgem.com/2017/12/18/brokers-set-expectations-for-xylem-incs-q2-2018-earnings-xyl.html.

About Xylem

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Earnings History and Estimates for Xylem (NYSE:XYL)

Receive News & Stock Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related stocks with our FREE daily email newsletter.